Renal Denervation Market Size, Share & Trends Analysis Report By Technology (Micro-Infusion, Ultrasound, Radiofrequency Based), By Region (Europe, APAC, MEA, North America), And Segment Forecasts, 2018 - 2026

Table of Contents

Chapter 1 Report Scope
                   1.1 Segment Market Scope
                   1.2 Regional Scope
                   1.3 Estimates and Forecast Timeline
Chapter 2 Methodology
                   2.1 Research Methodology
                       2.1.1 Information procurement
                   2.2 Information or Data Analysis
                   2.3 Market Formulation & Validation
                   2.4 Region Wise Market Calculation
                       2.4.1 Region Wise Market: Base Estimates
                       2.4.2 Global Market: CAGR Calculation
                   2.5 Region-Based Segment Share Calculation
                   2.6 Model Details
                       2.6.1 Commodity flow analysis (Model 1)
                       2.6.2 Volume price analysis (model 2)
                   2.7 List of Secondary Sources
                   2.8 List of Primary Sources
                   2.9 List of Abbreviations
Chapter 3 Objectives
                   3.1 Objective - 1: Understanding the market dynamics
                   3.2 Objective - 2: Understanding the market estimates and forecasts
                   3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization
                   3.4 Objective - 4: Understanding the key end-users, technological, application and product scopes
Chapter 4 Executive Summary
Chapter 5 Market Definition
Chapter 6 Industry Outlook
                   6.1 Market Segmentation
                   6.2 Business Segment Trends
                       6.2.1 Product business analysis
                       6.2.2 Regional business analysis
                   6.3 Market Variable Analysis
                       6.3.1 Market driver analysis
                           6.3.1.1 Growing prevalence of hypertension
                           6.3.1.2 Changing lifestyle of people
                           6.3.1.3 Enduring effect of the procedure
                       6.3.2 Market restraint analysis
                           6.3.2.1 Painful procedure
                   6.4 Penetration & Growth Prospect Mapping
                   6.5 Business Environment Analysis tools
                       6.5.1 SWOT Analysis, by PEST
                           6.5.1.1 Political & Legal
                           6.5.1.2 Economic
                           6.5.1.3 Technological
                       6.5.2 Porter’s five forces analysis
                           6.5.2.1 Bargaining power of buyers: Low
                           6.5.2.2 Bargaining power of suppliers: High
                           6.5.2.3 Competitive rivalry: High
                           6.5.2.4 Threat of new entrants: Moderate
                           6.5.2.5 Threat of substitutes: Low
                       6.5.3 Industry Analysis - Ansoff’s Matrix
Chapter 7 Renal Denervation Market: Technology Estimates & Trend Analysis
                   7.1 Renal Denervation Market: Product Movement Analysis
                   7.2 Radiofrequency Based on Renal Denervation
                       7.2.1 Radiofrequency based renal denervation market, 2014 - 2026 (USD Million)
                   7.3 Ultrasound Based Renal Denervation
                       7.3.1 Ultrasound based renal denervation market, 2014 - 2026 (USD Million)
                   7.4 Micro-Infusion Based on Renal Denervation
                       7.4.1 Micro-Infusion based renal denervation market, 2014 - 2026 (USD Million)
Chapter 8 Renal Denervation Market: Region Estimates & Trend Analysis, by Technology
                   8.1 Renal Denervation Market: Region Movement Analysis
                   8.2 North America
                       8.2.1 North America renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.2.2 U.S.
                           8.2.2.1 U.S. renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.2.3 Canada
                           8.2.3.1 Canada renal denervation market, by technology, 2014 - 2026 (USD Million)
                   8.3 Europe
                       8.3.1 Europe renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.3.2 U.K.
                           8.3.2.1 U.K. renal denervation market, by technology,2014 - 2026 (USD Million)
                       8.3.3 Germany
                           8.3.3.1 Germany renal denervation market, by technology, 2014 - 2026 (USD Million)
                   8.4 Asia Pacific
                       8.4.1 Asia Pacific renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.4.2 Japan
                           8.4.2.1 Japan renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.4.3 China
                           8.4.3.2 China renal denervation market, by technology, 2014 - 2026 (USD Million)
                   8.5 Latin America
                       8.5.1 Latin America renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.5.2 Brazil
                           8.5.2.1 Brazil renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.5.3 Mexico
                           8.5.3.1 Mexico renal denervation market, by technology, 2014 - 2026 (USD Million)
                   8.6 MEA
                       8.6.1 MEA renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.6.2 South Africa
                           8.6.2.1 South Africa renal denervation market, by technology, 2014 - 2026 (USD Million)
                       8.6.3 Saudi Arabia
                           8.6.3.1 Saudi Arabia renal denervation market, by technology, 2014 - 2026 (USD Million)
Chapter 9 Company Profiles
                   9.1 Strategic Framework
                   9.2 Company Profiles
                       9.2.1 Medtronic
                           9.2.1.1 Company overview
                           9.2.1.2 Financial performance
                           9.2.1.3 Product benchmarking
                           9.2.1.4 Strategic initiatives
                       9.2.2 Kona Medical
                           9.2.2.1 Company overview
                           9.2.2.2 Financial performance
                           9.2.2.3 Product benchmarking
                           9.2.2.4 Strategic initiatives
                       9.2.3 Abbott
                           9.2.3.1 Company overview
                           9.2.3.2 Financial performance
                           9.2.3.3 Service benchmarking
                           9.2.3.4 Strategic initiatives
                       9.2.4 CardioSonic
                           9.2.4.1 Company overview
                           9.2.4.2 Product benchmarking
                           9.2.4.3 Strategic initiatives
                       9.2.5 Renal Dynamics
                           9.2.5.1 Company overview
                           9.2.5.2 Product benchmarking
                           9.2.5.3 Strategic initiatives
                       9.2.6 ReCor Medical
                           9.2.6.1 Company overview
                           9.2.6.2 Financial performance
                           9.2.6.3 Product benchmarking
                           9.2.6.4 Strategic initiatives
                       9.2.7 Boston Scientific Group
                           9.2.7.1 Company overview
                           9.2.7.2 Financial performance
                           9.2.7.3 Product benchmarking
                           9.2.7.4 Strategic initiatives
                       9.2.8 Symple Surgical
                           9.2.8.1 Company overview
                           9.2.8.2 Product benchmarking
                       9.2.9 Ablative Solutions
                           9.2.9.1 Company overview
                           9.2.9.2 Financial performance
                           9.2.9.3 Product benchmarking
                           9.2.9.4 Strategic initiatives
                       9.2.10 Mercator MedSystems
                           9.2.10.1 Company overview
                           9.2.10.2 Financial performance
                           9.2.10.3 Product benchmarking
                           9.2.10.4 Strategic initiatives
Chapter 10 KOL Commentary
                   10.1 Key Insights
                   10.2 KOL Views
Chapter 11 Recommendations

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 Leading market players anticipated witnessing the highest growth
Table 4 Global Renal Denervation Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million)
Table 5 Global Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 6 North America Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 7 North America Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 8 U.S. Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 9 Canada Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 10 Europe Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 11 Europe Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 12 U.K. Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 13 Germany Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 14 Asia Pacific Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 15 Asia Pacific Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 16 China Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 17 Japan Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 18 Latin America Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 19 Latin America Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 20 Brazil Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 21 Mexico Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 22 MEA Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 23 MEA Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 24 South Africa Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 25 Saudi Arabia Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)

List of Figures

Fig.1 Market research process
Fig.2 Information procurement
Fig.3 Primary research pattern
Fig.4 Market research approaches
Fig.5 Value chain based sizing & forecasting
Fig.6 QFD modeling for market share assessment
Fig.7 Market formulation & validation
Fig.8 Renal denervation market segmentation
Fig.9 Market driver relevance analysis (Current & future impact)
Fig.10 Market restraint relevance analysis (Current & future impact)
Fig.11 SWOT analysis, by a factor (political & legal, economic and technological)
Fig.12 Porter’s five forces analysis
Fig.13 Ansoff’s matrix analysis
Fig.14 Renal denervation market product outlook: Key takeaways
Fig.15 Renal denervation market: Product movement analysis
Fig.16 Radiofrequency based renal denervation market, 2014 - 2026 (USD Million)
Fig.17 Ultrasound based renal denervation market, 2014 - 2026 (USD Million)
Fig.18 Micro-infusion based renal denervation market, 2014 - 2026 (USD Million)
Fig.19 Regional market place: Key takeaways
Fig.20 Renal denervation market: Region movement analysis
Fig.21 North America renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.22 U.S. renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.23 Canada renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.24 Europe renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.25 U.K. renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.26 Germany renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.27 Asia Pacific renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.28 Japan renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.29 China renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.30 Latin America renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.31 Brazil renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.32 Mexico renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.33 MEA renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.34 South Africa renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.35 Saudi Arabia renal denervation market, by technology, 2014 - 2026 (USD Million)